Status:
COMPLETED
Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
Research Foundation for Mental Hygiene, Inc.
National Institute on Drug Abuse (NIDA)
Conditions:
Marijuana Smoking
Eligibility:
All Genders
21-45 years
Phase:
PHASE2
Brief Summary
In heavy marijuana smokers, opioid receptor blockade increases the subjective and cardiovascular effects of marijuana. The current study was designed to clarify opioid-cannabinoid interactions by asse...
Eligibility Criteria
Inclusion
- Current marijuana use
- Able to perform study procedures
- Women practicing an effective form of birth control
Exclusion
- Current repeated illicit drug use (other than marijuana)
- Presence of significant medical illness (e.g., diabetes, cardiovascular disease,hypertension, hepatitis, clinically significant laboratory abnormalities, LFTs \> 3x upper limit of normal, blood pressure \> 140/90
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00743145
Start Date
May 1 2008
End Date
September 1 2009
Last Update
September 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032